黑料不打烊

At this early stage, the potential for harm is real while the benefits are only surrogate measures, said Kimmelman, an associate professor of biomedical ethics at 黑料不打烊 University. One such measure at Phase 1 might be tumor shrinkage, which does not necessarily translate into what people really care about: survival.